Prove Value & Win Coverage with HEOR Consulting
Our HEOR consulting team fuses real‑world evidence with rigorous economic models, giving payers the ROI clarity they need to green‑light coverage sooner.
The Evidence‑Value Gap in Medical Device & IVD
Regulators open the door, but payers, HTA agencies, and hospital value committees hold the keys to commercial success. They want clear proof that your technology lowers costs, improves outcomes, or both—and they want that proof in economic language they trust. Without a plan that fuses clinical results with real‑world evidence and budget‑impact data, even breakthrough innovations can languish unfunded while competitors surge ahead.
- Payers invest in cost offsets and measurable outcome gains, not just clinical efficacy.
- Devices often lack post‑market, Phase IV‑style data; IVDs face scattered value frameworks.
- Mis‑sequenced studies can burn millions and add 12 + months to coverage timelines.
Our health economics and outcomes research consulting model closes this gap by aligning study design, economic modelling, and value communication from day one.
Our Integrated Evidence‑Planning Engine
Built for devices, diagnostics, and digital health—stress tested with payers.
Headline
Evidence Impact Scoring
What we do: Quantify every proposed study’s lift on payer acceptance vs. cost.
Your advantage: Invest only in research that moves market access odds.

Headline
Cross Functional Design
What we do: Biostats, health economists, clin reg and reimbursement consulting strategists co create one plan.
Your advantage: No hand offs; one accountable team.

Headline
Iterative Validaton
What we do: Live payer panels vet value messages before protocols lock.
Your advantage: Minimize redesigns and HTA surprises.

Headline
Pull Through Execution
What we do: We build economic models, run real world evidence analyses, and author value dossiers
Your advantage: Faster “evidence to impact” cycle.


Comprehensive HEOR Consulting Services
Before diving into the workstreams, it’s key to see how each module supports one unified, payer-ready story. As Joseph Ferrara says, “Economic proof without clinical context falls flat—and vice versa.” That’s why every deliverable we create is:
- Strategically sequenced inside an Integrated Evidence Plan, so you collect the right data at the right time—never “study for study’s sake.”
- Payer‑validated up‑front, using our live advisory panels to test messages before they harden into protocols or models.
- Built for pull‑through, meaning the same team that models the budget impact also crafts the AMCP or NICE dossier and coaches your field team on the narrative.
Think of the modules as building blocks—use one now or combine several for a full evidence program, from pre-market pricing to post-market HTA renewals.
-
Economic Models & Budget‑Impact Analysis
Cost‑effectiveness models, budget‑impact models, price‑elasticity corridors.
-
Real‑World Evidence & Narrative
Transform registries, claims, and EMR data into persuasive real‑world evidence (RWE). We surface utilization, outcomes, and economic signals that strengthen your coverage story and disarm the “evidence gap” objection.
-
Value Dossiers & HTA Submissions
Package the science and the economics into a single, regulator‑ready file. From AMCP dossiers to NICE and G‑BA submissions, we craft value communication that passes HTA scrutiny and accelerates positive decisions.
-
Publication & Communication Strategy
Multiply impact with peer‑reviewed papers, congress abstracts, and payer slide decks—all authored by the same experts who built your models. One narrative, many channels—maximizing credibility and field‑team adoption.
Related Articles
Latest Blog Entries
Health Economics and Outcomes Research Case Studies
Real-world Evidence and Economic Modelling Working Together to Unlock Faster Payer Decisions
Paving Value for a Precision‑Medicine CDx
Situation
An oncology companion‑diagnostic developer needed a single payer‑ready narrative across the U.S. and three EU markets.
Successes
- Country‑specific cost‑consequence model in 8 weeks.
- Unified evidence library synthesized from RWE.
- Interactive value‑communication tool adopted by 4 top payers within 90 days.
Services by Veranex
- Economic Modelling
- RWE Synthesis
- Value Dossier & Communication
Discover More
Related Services at Veranex
Integrated Evidence Planning (IEP)
Integrated Evidence Planning (IEP)
Align regulatory, clinical, and economic studies in one roadmap.

Market Access Strategy & Reimbursement
Market Access Strategy & Reimbursement
Secure the codes, payment, and coverage your evidence deserves.

Customer Insights & Market Analytics
Customer Insights & Market Analytics
Model market size and adoption before you invest in evidence.

Growth, M&A & Innovation Strategy
Growth, M&A & Innovation Strategy
Prioritize portfolios and deals with evidence backed forecasts.

Start Your Evidence Plan with Veranex HEOR Consulting
Unite real-world evidence, economic models, and payer-tested messaging in a single roadmap—so coverage decisions arrive sooner, and revenue follows faster.



